Dana H. Shin

Array ( [id] => 6957952 [patent_doc_number] => 20050214322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Vaccines containing a saponin and a sterol' [patent_app_type] => utility [patent_app_number] => 10/967395 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4903 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214322.pdf [firstpage_image] =>[orig_patent_app_number] => 10967395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726831 [patent_doc_number] => 20060057591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method for preventing viral infection' [patent_app_type] => utility [patent_app_number] => 10/940642 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9162 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057591.pdf [firstpage_image] =>[orig_patent_app_number] => 10940642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224713 [patent_doc_number] => 20070253979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Immunogenic Hiv Compositions and Related Methods' [patent_app_type] => utility [patent_app_number] => 10/570177 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 16455 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253979.pdf [firstpage_image] =>[orig_patent_app_number] => 10570177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918758 [patent_doc_number] => 20050096319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 10/920831 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 57255 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096319.pdf [firstpage_image] =>[orig_patent_app_number] => 10920831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426688 [patent_doc_number] => 20040265801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Immunoassays for anti-HCV antibodies' [patent_app_type] => new [patent_app_number] => 10/899715 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265801.pdf [firstpage_image] =>[orig_patent_app_number] => 10899715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111869 [patent_doc_number] => 07713535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Modulation of immunostimulatory properties by small oligonucleotide-based compounds' [patent_app_type] => utility [patent_app_number] => 10/852598 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 40 [patent_no_of_words] => 22176 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713535.pdf [firstpage_image] =>[orig_patent_app_number] => 10852598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925392 [patent_doc_number] => 20050238647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Therapeutic uses for MDC and MDC antagonists' [patent_app_type] => utility [patent_app_number] => 10/818952 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39416 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238647.pdf [firstpage_image] =>[orig_patent_app_number] => 10818952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383742 [patent_doc_number] => 20040180050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease' [patent_app_type] => new [patent_app_number] => 10/808789 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11552 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180050.pdf [firstpage_image] =>[orig_patent_app_number] => 10808789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624881 [patent_doc_number] => 20060263386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 10/550754 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10262 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263386.pdf [firstpage_image] =>[orig_patent_app_number] => 10550754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999364 [patent_doc_number] => 20070041998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 10/550820 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5088 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041998.pdf [firstpage_image] =>[orig_patent_app_number] => 10550820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699618 [patent_doc_number] => 20060216302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Immunological markers' [patent_app_type] => utility [patent_app_number] => 10/547046 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17119 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216302.pdf [firstpage_image] =>[orig_patent_app_number] => 10547046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677170 [patent_doc_number] => 20040152656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/788191 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11312 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152656.pdf [firstpage_image] =>[orig_patent_app_number] => 10788191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672886 [patent_doc_number] => 20040180893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/783053 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29301 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180893.pdf [firstpage_image] =>[orig_patent_app_number] => 10783053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483378 [patent_doc_number] => 07220768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus' [patent_app_type] => utility [patent_app_number] => 10/772799 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5209 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220768.pdf [firstpage_image] =>[orig_patent_app_number] => 10772799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225303 [patent_doc_number] => 20050255097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Modified venom and venom components as anti-retroviral agents' [patent_app_type] => utility [patent_app_number] => 10/764356 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10120 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255097.pdf [firstpage_image] =>[orig_patent_app_number] => 10764356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163155 [patent_doc_number] => 20050085435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel inhibitors of poxvirus replication' [patent_app_type] => utility [patent_app_number] => 10/750939 [patent_app_country] => US [patent_app_date] => 2004-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 8641 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085435.pdf [firstpage_image] =>[orig_patent_app_number] => 10750939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425706 [patent_doc_number] => 20040161470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Preparation of polyphosphazene microspheres' [patent_app_type] => new [patent_app_number] => 10/715787 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3220 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161470.pdf [firstpage_image] =>[orig_patent_app_number] => 10715787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63007 [patent_doc_number] => 07758876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/533634 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19913 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/758/07758876.pdf [firstpage_image] =>[orig_patent_app_number] => 10533634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410850 [patent_doc_number] => 20040106539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Agents for the treatment of viral infections' [patent_app_type] => new [patent_app_number] => 10/398993 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30294 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106539.pdf [firstpage_image] =>[orig_patent_app_number] => 10398993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333201 [patent_doc_number] => 20040131604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods for inhibiting viral replication in vivo' [patent_app_type] => new [patent_app_number] => 10/674666 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18091 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131604.pdf [firstpage_image] =>[orig_patent_app_number] => 10674666 [rel_patent_id] =>[rel_patent_doc_number] =>)